Literature DB >> 19150352

Reverse calcium affinity purification of Fab with calcium derivatized hydroxyapatite.

Pete Gagnon1, Chia-Wei Cheung, Paul J Yazaki.   

Abstract

This study introduces the application of calcium-derivatized hydroxyapatite for purification of Fab. Fab binds to native hydroxyapatite but fails to bind to the calcium derivatized form. IgG, Fc, and most other protein contaminants bind to the calcium form. This supports Fab purification by a simple flow-through method that achieves greater than 95% purity from papain digests and mammalian cell culture supernatants. Alternatively, Fab can be concentrated on native hydroxyapatite then eluted selectively by conversion to the calcium-derivatized form.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150352      PMCID: PMC3171993          DOI: 10.1016/j.jim.2008.11.021

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  A dual-mode approach to the selective separation of antibodies and their fragments.

Authors:  L Guerrier; I Flayeux; E Boschetti
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-05-05

2.  Antibody variable region interactions with Protein A: implications for the development of generic purification processes.

Authors:  Sanchayita Ghose; Martin Allen; Brian Hubbard; Clayton Brooks; Steven M Cramer
Journal:  Biotechnol Bioeng       Date:  2005-12-20       Impact factor: 4.530

3.  On the interaction between single chain Fv antibodies and bacterial immunoglobulin-binding proteins.

Authors:  B Akerström; B H Nilson; H R Hoogenboom; L Björck
Journal:  J Immunol Methods       Date:  1994-12-28       Impact factor: 2.303

4.  Preparation and characterization of the F (ab)2 fragments of an aromatase activity-suppressing monoclonal antibody.

Authors:  P C Ng; Y Osawa
Journal:  Steroids       Date:  1997-12       Impact factor: 2.668

5.  The interaction of proteins with hydroxyapatite. II. Role of acidic and basic groups.

Authors:  M J Gorbunoff
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  The interaction of proteins with hydroxyapatite. III. Mechanism.

Authors:  M J Gorbunoff; S N Timasheff
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

7.  Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments.

Authors:  M Bowles; S C Johnston; D D Schoof; P R Pentel; S M Pond
Journal:  Int J Immunopharmacol       Date:  1988

8.  Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup.

Authors:  E H Sasso; G J Silverman; M Mannik
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

9.  The interaction of proteins with hydroxyapatite. I. Role of protein charge and structure.

Authors:  M J Gorbunoff
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

  9 in total
  4 in total

1.  Cooperative multimodal retention of IgG, fragments, and aggregates on hydroxyapatite.

Authors:  Pete Gagnon; Chia-Wei Cheung; Paul J Yazaki
Journal:  J Sep Sci       Date:  2009-11       Impact factor: 3.645

2.  Minibodies and Multimodal Chromatography Methods: A Convergence of Challenge and Opportunity.

Authors:  Pete Gagnon; Chia-Wei Cheung; Eric J Lepin; Anna M Wu; Mark A Sherman; Andrew A Raubitschek; Paul J Yazaki
Journal:  Bioprocess Int       Date:  2010-02

3.  Immunoglobulin G in Platelet-Derived Wound Healing Factors.

Authors:  Elisa Seria; Sarah Samut Tagliaferro; Doreen Cutajar; Ruth Galdies; Alex Felice
Journal:  Biomed Res Int       Date:  2021-01-28       Impact factor: 3.411

4.  A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer's disease brain.

Authors:  Andrew M Stern; Lei Liu; Shanxue Jin; Wen Liu; Angela L Meunier; Maria Ericsson; Michael B Miller; Megan Batson; Tingwan Sun; Sagar Kathuria; David Reczek; Laurent Pradier; Dennis J Selkoe
Journal:  Brain       Date:  2022-07-29       Impact factor: 15.255

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.